BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25264598)

  • 1. Intracardiac Thrombosis after Emergent Prothrombin Complex Concentrate Administration for Warfarin Reversal.
    Goldhammer JE; Bakowitz MJ; Milas BL; Patel PA
    Anesthesiology; 2015 Aug; 123(2):458. PubMed ID: 25264598
    [No Abstract]   [Full Text] [Related]  

  • 2. Massive, fatal, intracardiac thrombosis associated with prothrombin complex concentrate.
    Warren O; Simon B
    Ann Emerg Med; 2009 Jun; 53(6):758-61. PubMed ID: 19181420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixed dose 4-factor prothrombin complex concentrate for the emergent reversal of warfarin: a retrospective analysis.
    Astrup G; Sarangarm P; Burnett A
    J Thromb Thrombolysis; 2018 Feb; 45(2):300-305. PubMed ID: 29164374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dangers of prothrombin complex concentrate administration after heart surgery.
    White R; Rushbrook J; McGoldrick J
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):609-10. PubMed ID: 18685448
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimisation of the prothrombin complex concentrate dose for warfarin reversal.
    Makris M
    Thromb Res; 2005; 115(6):451-3. PubMed ID: 15792674
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative effectiveness of 3- versus 4-factor prothrombin complex concentrate for emergent warfarin reversal.
    Voils SA; Holder MC; Premraj S; Catlin JR; Allen BR
    Thromb Res; 2015 Sep; 136(3):595-8. PubMed ID: 26233569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic complications following the administration of high-dose prothrombin complex concentrate for acute warfarin reversal.
    Zemrak WR; Kelley E; Kovacic NL; Mooney DM; Morris JG; MacVane CZ; Rosenblatt JA
    Am J Emerg Med; 2016 Aug; 34(8):1736.e1-3. PubMed ID: 26806175
    [No Abstract]   [Full Text] [Related]  

  • 8. Fixed dose prothrombin complex concentrate for the reversal of oral anticoagulation therapy.
    Junagade P; Grace R; Gover P
    Hematology; 2007 Oct; 12(5):439-40. PubMed ID: 17852462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding.
    Stewart WS; Pettit H
    Am J Emerg Med; 2013 Aug; 31(8):1251-4. PubMed ID: 23763937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid large pulmonary embolism after prothrombin complex concentrate for warfarin reversal during colonoscopy.
    Keung CYY; Metz AJ; Sood S
    Intern Med J; 2017 Jun; 47(6):710-711. PubMed ID: 28580741
    [No Abstract]   [Full Text] [Related]  

  • 11. Limb-threatening Deep Venous Thrombosis Complicating Warfarin Reversal with Three-factor Prothrombin Complex Concentrate: A Case Report.
    Jablow LM; Jones CW; Carroll GG; Wilsey SV; Haroz R
    J Emerg Med; 2016 Jan; 50(1):28-31. PubMed ID: 26603365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of intracardiac thromboses after factor VIII inhibitor bypass activity administration by transesophageal echocardiography.
    Horstman DJ; van der Starre PJ
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):561-3. PubMed ID: 17678785
    [No Abstract]   [Full Text] [Related]  

  • 13. What happens after prothrombin complex concentrate administration?
    Horton S; Heath R; Houghton A; Martlew V; Thachil J
    Eur J Intern Med; 2013 Apr; 24(3):e48-9. PubMed ID: 23044171
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of fixed dose 4-factor prothrombin complex concentrate for emergent warfarin reversal.
    Klein L; Peters J; Miner J; Gorlin J
    Am J Emerg Med; 2015 Sep; 33(9):1213-8. PubMed ID: 26143315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department.
    Hickey M; Gatien M; Taljaard M; Aujnarain A; Giulivi A; Perry JJ
    Circulation; 2013 Jul; 128(4):360-4. PubMed ID: 23770745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kcentra: a 4-factor prothrombin complex concentrate for reversal of warfarin anticoagulation.
    Med Lett Drugs Ther; 2013 Jul; 55(1420):53-4. PubMed ID: 23836371
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of prothrombin complex concentrate on INR and blood coagulation system in emergency patients treated with warfarin overdose.
    Yasaka M; Oomura M; Ikeno K; Naritomi H; Minematsu K
    Ann Hematol; 2003 Feb; 82(2):121-3. PubMed ID: 12601493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the dose of three-factor prothrombin complex concentrate in traumatic brain injury patients on warfarin therapy.
    Huynh TK; Costello JL; Rebuck JA
    Pharmacotherapy; 2014 Mar; 34(3):260-4. PubMed ID: 24338807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombin complex concentrate (PCC, Octaplex) in patients requiring immediate reversal of vitamin K antagonist anticoagulation.
    Song MM; Warne CP; Crowther MA
    Thromb Res; 2012 Apr; 129(4):526-9. PubMed ID: 22304928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.